Multicenter Prospective Observational Study Evaluating the Management of Heart Failure
- Conditions
- Heart Failure
- Interventions
- Other: Questionnaies
- Registration Number
- NCT05180370
- Lead Sponsor
- AstraZeneca Turkey
- Brief Summary
ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study.
- Detailed Description
ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study. Data entry staff who will be assigned to the centers for 2 weeks will apply a questionnaire consisting of different questions to the patients referred to them by clinicians with the diagnosis of HF. In addition, Pittsburg Sleep Quality Index will be applied to all cases. In addition, clinical features of HF from the current file of the cases (NYHA, comorbid conditions, comorbid diseases, blood pressure, heart rate, last drugs used, latest biochemistry (BNP/NTproBNP if available), hematology test results, most recent ECG , most recent echocardiography, coronary angiography report, if available) will be recorded. No additional examination/procedure will be performed for the study, only the data of the examinations requested by the clinician in routine clinical practice will be entered. A total of 500 patients from 10 centers will be included in this study over a six-month period.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 500
- Outpatient or inpatient diagnosed with Heart Failure at least 6 months ago
- Male or female patient aged 18 and over
- Signed written informed consent form
- newly diagnosed heart failure
- CRY requiring dialysis
- Serious liver and lung disease
- LVAD/heart transplantation
- HF due to possible temporary cause (myocarditis, peripartum CMP in the first 6 months, takotsubo etc.)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Outpatient or inpatient diagnosed with Heart Failure at least 6 months ago Questionnaies ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study.
- Primary Outcome Measures
Name Time Method General Status of the patients 6 months At the end of the six-month recruitment period, demographic, symptoms, clinical follow-up status, disease information, treatment compliance, and awareness assessment will be performed on all included patients.
- Secondary Outcome Measures
Name Time Method HF Comorbidities 6 Months HF ECHO Results 6 Months HF Risk Factors 6 Months Medications Used for HF 6 Months HF Laboratory Results 6 Months HF Percutaneous Intervention History & Operation History 6 Months
Trial Locations
- Locations (10)
Dokuz Eylül University Medical Faculty
🇹🇷İzmir, Turkey
Tepecik Training and Research Hospital
🇹🇷İzmir, Turkey
Mersin University Medical Faculty
🇹🇷Mersin, Turkey
Ankara City Hospital
🇹🇷Ankara, Turkey
Akdeniz University Medical Faculty
🇹🇷Antalya, Turkey
Eskişehir Osmangazi University Medical Faculty
🇹🇷Eskişehir, Turkey
Istanbul University - Cerrahpaşa, Cardiology Institute
🇹🇷Istanbul, Turkey
Başkent University Istanbul Health Practice and Research Center Hospital
🇹🇷Istanbul, Turkey
Dr. Siyami Ersek Chest Cardiac and Vascular Surgery T&R Hospital
🇹🇷Istanbul, Turkey
Ege University Medical Faculty
🇹🇷İzmir, Turkey